Gene and Cell Therapy – Multimedia

In this cell and gene therapy insights expert roundtable, a panel of four experts will answer some central questions surrounding the development of novel biotherapeutics.

Download this app note to discover immunoassay platforms that are consistent for your cell therapy and immunology development needs.

Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.

Download this listicle to learn about recent advances in cell-based therapies including off-the-shelf chimeric antigen receptor (CAR) T-cell therapy, engineered T-cell receptor therapy and mesenchymal stem cell therapies.

Download this poster to discover a novel xeno-free culture system that can facilitate the development of a robust, clinically acceptable culture process and maintains MSC features.

Download this info kit to discover solutions that can analyze compounds with positive or negative polarity and provide easy-to-use kits for a variety of protein workflows.

Gene therapy is rapidly gaining importance as a critical treatment modality in the prevention or cure of a wide range of diseases. However, getting a product to market for commercial use does not come without its challenges.

Adeno-associated virus (AAV) has shown great potential as a delivery vector for therapeutic genes and is becoming a tool of choice for many emerging gene therapies.

Gene therapy is an effective tool for modifying genetic material within a cell. This pioneering form of precision medicine addresses health conditions caused by mutated, faulty or malfunctioning genes within cells.

Cell therapy represents one of the most exciting areas of advancement in life sciences. From tissue transplants to using the body’s own immune system to attack pathogens, it has all been made possible by both the early breakthroughs and ongoing research successes.